Kamal Amin

Recent studies indicate that 70% of clinical trial professionals report experiencing supply disruptions due to regional variability and unexpected risks, showcasing the need for robust risk management strategies. Effective planning and execution are essential to avoid delays and protect the integrity of trials. Managing global clinical trial supplies involves navigating a complex web of challenges. These include region-specific regulatory requirements, geopolitical risks, logistical obstacles, and supply chain vulnerabilities. The rise of decentralized trials and the integration of personalized therapies add further intricacies. This panel will explore how organizations can proactively identify and mitigate risks to ensure a seamless supply process for trials spanning multiple regions.

Key Topics to be Addressed:

• Risk Identification and Mitigation Frameworks: Best practices for identifying and addressing potential disruptions before they escalate.
• Navigating Regional Regulatory Challenges: Strategies to streamline compliance across diverse regulatory landscapes.
• Contingency Planning for Crisis Scenarios: Preparing for geopolitical, logistical, and natural disaster-related disruptions

The panel discussion will address establishing communication and collaboration pathways between GMP and GCP teams. We look to address discrepancies between GMP and GCP requirements, emphasizing cross-departmental collaboration and shared goals.